These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19858689)

  • 1. Cost-effectiveness analysis and health policy.
    Torgerson DJ
    Nestle Nutr Workshop Ser Clin Perform Programme; 2009; 12():95-104. PubMed ID: 19858689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinician's guide to cost-effectiveness analysis.
    Detsky AS; Naglie IG
    Ann Intern Med; 1990 Jul; 113(2):147-54. PubMed ID: 2113784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How much does the society want to pay?].
    Norheim OF
    Tidsskr Nor Laegeforen; 2003 Feb; 123(3):303. PubMed ID: 12640893
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh.
    Teerawattananon Y; Tantivess S; Yamabhai I; Tritasavit N; Walker DG; Cohen JT; Neumann PJ
    Health Res Policy Syst; 2016 Dec; 14(1):86. PubMed ID: 27912780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who cares about cost? Does economic analysis impose or reflect social values?
    Nord E; Richardson J; Street A; Kuhse H; Singer P
    Health Policy; 1995 Nov; 34(2):79-94. PubMed ID: 10153484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities.
    Hoffmann C; Stoykova BA; Nixon J; Glanville JM; Misso K; Drummond MF
    Value Health; 2002; 5(2):71-8. PubMed ID: 11918822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choosing between competing health priorities. A government payer perspective.
    Leese J
    Pharmacoeconomics; 1996; 9 Suppl 3():4-7; discussion 23-5. PubMed ID: 10160486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis for priority-setting in South Africa--what are the possibilities?
    Doherty J
    S Afr Med J; 2010 Dec; 100(12):816-21. PubMed ID: 21414274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limits to rationality: economics, economists and priority setting.
    Robinson R
    Health Policy; 1999 Oct; 49(1-2):13-26. PubMed ID: 10827288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of cost-effectiveness and cost-benefit analyses in industrialized countries.
    Drummond MF
    World Health Stat Q; 1985; 38(4):383-401. PubMed ID: 3938110
    [No Abstract]   [Full Text] [Related]  

  • 11. The importance of patient preferences for comorbidities in cost-effectiveness analyses.
    Harris RA; Nease RF
    J Health Econ; 1997 Feb; 16(1):113-9. PubMed ID: 10167342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prioritization and health--should maximum-price life years be introduced?].
    Kristiansen IS; Gyrd-Hansen D
    Tidsskr Nor Laegeforen; 2007 Jan; 127(1):54-7. PubMed ID: 17205092
    [No Abstract]   [Full Text] [Related]  

  • 13. [Health care politicians are not concerned about maximum health gain per crown].
    Nord E
    Tidsskr Nor Laegeforen; 1993 Apr; 113(11):1371-3. PubMed ID: 8337630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health economics, economic evaluation, and glaucoma.
    Kobelt G
    J Glaucoma; 2002 Dec; 11(6):531-9. PubMed ID: 12483101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation and health care decision-making.
    Rutten F
    Health Policy; 1996 Jun; 36(3):215-29. PubMed ID: 10158267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allocating resources.
    Drummond MF
    Int J Technol Assess Health Care; 1990; 6(1):77-92. PubMed ID: 2113892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.
    Neumann PJ; Cohen JT; Weinstein MC
    N Engl J Med; 2014 Aug; 371(9):796-7. PubMed ID: 25162885
    [No Abstract]   [Full Text] [Related]  

  • 18. Economic evaluation methods and health policy.
    Stoddart GL
    Eval Health Prof; 1982 Dec; 5(4):393-414. PubMed ID: 10309791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Economic Evidence to Set Healthcare Priorities in Low-Income and Lower-Middle-Income Countries: A Systematic Review of Methodological Frameworks.
    Wiseman V; Mitton C; Doyle-Waters MM; Drake T; Conteh L; Newall AT; Onwujekwe O; Jan S
    Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):140-61. PubMed ID: 26804361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health economic studies: an introduction to cost-benefit, cost-effectiveness, and cost-utility analyses.
    Angevine PD; Berven S
    Spine (Phila Pa 1976); 2014 Oct; 39(22 Suppl 1):S9-15. PubMed ID: 25299265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.